Press "Enter" to skip to content

Plasma treatment approved for corona patients in america, WHO asks caution

US President Donald Trump (file photo)

US President Donald Trump welcomed the FDA’s decision that approved plasma treatment for patients with Covid-19.

Washington. The US health regulator has given an emergency approval for the use of blood plasma to treat patients with the coroanvirus and said the benefits of this treatment outweigh any potential risks. The US Food and Drug Administration (FDA) said on Sunday that more than 70,000 patients were treated with condensed plasma in the country and that the plasma is taken from the blood of people who have recovered from corona virus infection. US President Donald Trump welcomed the FDA’s move on the eve of the four-day Republican National Conference. Trump will again be named a Republican candidate for the presidential election on November 3.

Trump, referring to the Corona virus at the White House briefing, said, “Today I am happy to make a truly historic announcement in my fight against the China virus as it will save countless lives.” He said, ‘Today’s move will increase access to this treatment.’ In Geneva, the World Health Organization (WHO) said on Monday that the use of convalescent plasma is still a practical treatment. WHO’s chief scientist Soumya Swaminathan said that many clinical trials are still going on worldwide in the context of conjunctive plasma. Swaminathan, India’s pediatrician and top researcher on tuberculosis and HIV, said at the press conference, “Actually, only a few of them have had interim results … and at the moment, the evidence is of very poor quality.” He said that WHO still believes that plasma therapy is in the experimental phase and its evaluation should continue. He said that it is difficult to standardize this treatment because antibodies are produced at different levels in people and the plasma should be collected individually from recovered patients.

Donald Trump tweeted
A day before his announcement on plasma treatment, President Trump accused the FDA of obstructing vaccines and treatments for the disease for political reasons. Trump had tweeted, “The selfish element or whatever contained in the FDA is hindering drug companies from testing vaccines or treatments for people.” He said, “They are obviously looking forward to the delay (until the completion of the US presidential election).” The FDA said in its release that as part of its efforts in the fight against Kovid-19, it has approved the emergency use of plasma for hospitalization purposes on hospitalized Kovid-19 patients. Based on available scientific evidence, the FDA concluded that the product could be effective in the treatment of Kovid-19 and ‘its known and potential benefits outweigh its known and potential risks.’Also Read: Good News: Use of this vaccine on the nose will end corona

57 million people infected corona in America

According to Johns Hopkins University, more than 1,76,000 people have died of corona virus in the US and 57 lakh people have been infected in the country so far. US Health and Human Services Minister Alex Ezar said, “The FDA’s emergency approval for condensed plasma is a major achievement in President Trump’s effort to save lives from Kovid-19.” However, many health experts have expressed their reservations about the robustness of the plasma studies conducted so far, including Antony Fossey, a member of the White House workforce on the corona virus. George Jonathan Reiner, professor (medicine) at George Washington University, said, “The problem is that we do not have enough data on how effective conjunctive plasma is.”


Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *